Strengths
Ustar possesses a strong intellectual property portfolio with over 90 patent applications and 45 granted patents, providing a competitive edge in the biotechnology sector.
The company has established partnerships with over 3,000 medical institutions, enhancing its credibility and market reach.
Ustar's innovative POCT technology allows for rapid diagnostics, which is crucial in clinical settings for timely decision-making.
The comprehensive product range includes reagents and instruments tailored for various applications, catering to diverse customer needs.
Ustar's commitment to improving global health is reflected in its focus on effective diagnostic solutions for infectious diseases.
The user-friendly sample-to-result solutions streamline the testing process, making it accessible for healthcare professionals.
Recognition through multiple national and provincial awards underscores Ustar's technological advancements and industry leadership.
The company's positioning as a leader in the POCT molecular diagnostics market emphasizes its focus on innovation and accessibility in healthcare.